⌘K

Login Start Free

Home/Filings/4/0001104659-20-106199

4//SEC Filing

Campagna Jason 4

Accession 0001104659-20-106199

CIK 0001270073other

View on SEC.gov Company Profile

Filed

Sep 16, 8:00 PM ET

Accepted

Sep 17, 7:00 PM ET

Size

4.9 KB

Accession

0001104659-20-106199

Insider Transaction Report

Form 4

Period: 2020-09-15

INTERCEPT PHARMACEUTICALS, INC.ICPT

Chief Medical Officer

Transactions

Tax Payment
Common Stock
2020-09-15$43.41/sh−69$2,995→ 8,709 total

Footnotes (1)

[F1]Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock award previously granted to the reporting person.

Documents

1 file

4
tm2030989d1_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

INTERCEPT PHARMACEUTICALS, INC.

CIK 0001270073

Entity typeother

Related Parties

1

filerCIK 0001793338

Filing Metadata

Form type: 4
Filed: Sep 16, 8:00 PM ET
Accepted: Sep 17, 7:00 PM ET
Size: 4.9 KB

View on SEC.gov